Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction

BACKGROUND/AIMS: Cavernous transformation of the portal vein (CTPV) in cirrhotic patients with extrahepatic portal vein obstruction (EHPVO) was a relatively rare disease and had no consensus on the treatment. Our study aimed to explore the value of anticoagulation with warfarin treatment for CTPV ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yongjie, Zhuang, Zhiquan, Yu, Tianzhu, Zhang, Wen, Ma, Jingqin, Yu, Jiaze, Yan, Zhiping, Luo, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832773/
https://www.ncbi.nlm.nih.gov/pubmed/36631860
http://dx.doi.org/10.1186/s12959-023-00449-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832773/
https://www.ncbi.nlm.nih.gov/pubmed/36631860
http://dx.doi.org/10.1186/s12959-023-00449-8

Ejemplares similares